Author

Takanori Himuro

Observed names: Himuro, Takanori, T Himuro, T. Himuro

Institutions: Juntendo University, Juntendo University Hospital

Observed institutions: Juntendo University, Juntendo University Hospital

OpenAlex ID: A5029942837

Analysis of circulating tumour cell and the epithelial mesenchymal transition (EMT) status during eribulin-based treatment in 22 patients with metastatic breast cancer: a pilot study

2018 · Yoshiya Horimoto, Emi Tokuda, et al. · Journal of Translational Medicine · 71

Combination of Cancer Stem Cell Markers CD44 and CD24 Is Superior to ALDH1 as a Prognostic Indicator in Breast Cancer Patients with Distant Metastases

2016 · Yoshiya Horimoto, Atsushi Arakawa, et al. · PLoS ONE · 64

Differences in Ki67 expressions between pre- and post-neoadjuvant chemotherapy specimens might predict early recurrence of breast cancer

2017 · Emi Tokuda, Yoshiya Horimoto, et al. · Human Pathology · 40

Low FOXA1 expression predicts good response to neo-adjuvant chemotherapy resulting in good outcomes for luminal HER2-negative breast cancer cases

2014 · Y Horimoto, A Arakawa, et al. · British Journal of Cancer · 40

Protein expression and methylation of DNA repair genes hMLH1, hMSH2, MGMT and BRCA1 and their correlation with clinicopathological parameters and prognosis in basal‐like breast cancer

2013 · Yimit Alkam, Hiroyuki Mitomi, et al. · Histopathology · 27

Neutrophil-to-lymphocyte ratio and histological type might predict clinical responses to eriburin-based treatment in patients with metastatic breast cancer

2020 · Mayu Myojin, Yoshiya Horimoto, et al. · Breast Cancer · 23

Impact of circulating tumour cells on survival of eribulin-treated patients with metastatic breast cancer

2019 · Mayuko Ito, Yoshiya Horimoto, et al. · Medical Oncology · 17

Activated Caspase 3 Expression in Remnant Disease After Neoadjuvant Chemotherapy May Predict Outcomes of Breast Cancer Patients

2016 · Takanori Himuro, Yoshiya Horimoto, et al. · Annals of Surgical Oncology · 16

Menstrual cycle could affect Ki67 expression in estrogen receptor-positive breast cancer patients

2015 · Yoshiya Horimoto, Atsushi Arakawa, et al. · Journal of Clinical Pathology · 16

High FOXA1 protein expression might predict late recurrence in patients with estrogen-positive and HER2-negative breast cancer

2020 · Yoshiya Horimoto, Noriko Sasahara, et al. · Breast Cancer Research and Treatment · 14

Ki67 Heterogeneity in Estrogen Receptor–Positive Breast Cancers

2015 · Takanori Himuro, Yoshiya Horimoto, et al. · International Journal of Surgical Pathology · 12

Application of a 70-Gene Expression Profile to Japanese Breast Cancer Patients

2015 · Hideo Shimizu, Yoshiya Horimoto, et al. · Breast Care · 7

転移性乳癌の22人の患者におけるエリブリンに基づく治療中の循環腫瘍細胞および上皮間葉転換(emt)状態の分析:パイロット研究【jst・京大機械翻訳】

2018 · Yoshiya Horimoto, Tokuda Emi, et al.

Risk factors for locoregional recurrence after post-mastectomy radiation therapy (PMRT) and chemotherapy in patients with 4 or more metastatic nodes

2017 · M. Saito, K. Iijima, et al. · The Breast

Combination of CD44/24 is superior to ALDH1 as a prognostic indicator in metastatic breast cancer

2017 · Yoshiya Horimoto, Atsushi Arakawa, et al. · 日本病理学会会誌

Works count: 18

Citation count: 347

H-index: 11

I10-index: 11